Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.32 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.32 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.32 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16800085 | 1.00 | SLC22A6 (0.39) | SLC22A6TDP1SMN1; SMN2MAPTGABRR1 | |
| SCHEMBL14150311 | 1.00 | SLC22A6 (0.39) | SLC22A6TDP1SMN1; SMN2MAPTGABRR1 | |
| SCHEMBL14150407 | 0.88 | SLC22A6 (0.35) | SLC22A6TDP1SMN1; SMN2MAPTGABRR1 | |
| SCHEMBL14150406 | 0.88 | SLC22A6 (0.35) | SLC22A6TDP1SMN1; SMN2MAPTGABRR1 | |
| SCHEMBL21800994 | 0.84 | FOLH1 (0.43) | GRIK1GRIK2TSHR | |
| SCHEMBL5536864 | 0.77 | — | — | |
| SCHEMBL1226205 | 0.77 | — | — | |
| SCHEMBL4744380 | 0.77 | — | — | |
| SCHEMBL8254537 | 0.77 | — | — | |
| SCHEMBL6725633 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109294002-B | Controllable bidirectional three-dimensional deformation hydrogel film, preparation method thereof and flexible microelectrode array | 深圳先进技术研究院 | 2021-05-04 | — | — | CN | disclosed |
| WO-2020051920-A1 | CONTROLLED BIDIRECTIONAL THREE-DIMENSIONAL DEFORMATION HYDROGEL THIN FILM, PREPARATION METHOD THEREFOR, AND FLEXIBLE MICROELECTRODE ARRAY | 深圳先进技术研究院 | 2020-03-19 | — | — | WO | disclosed |
| US-8946468-B2 | Process for producing ester compound having an internal unsaturated bond or cyclic olefin | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2015-02-03 | — | — | US | disclosed |
| US-20120316360-A1 | PROCESS FOR PRODUCING ESTER COMPOUND HAVING a,ß-UNSATURATED BOND | OSAKA UNIVERSITY (JP) | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120316360-A1 | PROCESS FOR PRODUCING ESTER COMPOUND HAVING a,ß-UNSATURATED BOND | COASY, OXER1, ACSL1 | SLC22A6 4117/4885TDP1 4039/4885SMN1; SMN2 2898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.